Clinical trial / 1999
Oral glucose loading rapidly suppresses flow-mediated vasodilation and raises TBARS levels in subjects with normal, impaired, or diabetic glucose tolerance.
Researchers evaluated flow-mediated endothelium-dependent vasodilation, TBARS, and nitrite/nitrate during an oral glucose tolerance test in 58 participants with normal glucose tolerance (NGT), impaired glucose tolerance (IGT), or type 2 diabetes (DM). Flow-mediated vasodilation decreased after glucose loading at 1 and 2 hours in all groups (NGT: 7.53+/-0.40% fasting to 4.24+/-0.28% and 6.35+/-0.40%; IGT: 6.50+/-0.48% to 1.40+/-0.41% and 4.00+/-0.47%; DM: 4.77+/-0.37% to 1.35+/-0.38% and 1.29+/-0.29%). TBARS concentrations increased in parallel with plasma glucose in each group, while nitrite/nitrate concentrations did not change in any group.
- Study type
- Interventional oral glucose challenge study
- Who was studied
- 58 subjects (17 with normal glucose tolerance, 24 with impaired glucose tolerance, 17 with type 2 diabetes mellitus)
- What was measured
- Flow-mediated endothelium-dependent vasodilation, TBARS, and nitrite/nitrate levels
THE PAPER
Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.
Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H. J Am Coll Cardiol, 1999.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.